About Aspire Pharma
Aspire Pharma is a Healthcare company based in Petersfield (United Kingdom) founded in 2009, and was acquired by Morningside Pharmaceuticals in October 2022. Therapeutic drugs and medical devices are in-licensed and commercialized. Aspire Pharma has completed 3 acquisitions, including Cenote Pharma, Morningside Healthcare and Morningside Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Aspire Pharma was founded in 2009 as a British pharmaceutical company based in Petersfield, United Kingdom. Operations focus on in-licensing and commercializing therapeutic drugs and medical devices across categories such as anti-microbials, anti-fungals, proton pump inhibitors, anti-allergy treatments, cardiac medications, central nervous system and psychiatry products, and analgesics. The company serves the traditional pharma sector with a portfolio targeted at various therapeutic needs.
- Headquarters Petersfield, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aspirepharma.co.uk
- Social LinkedIn
- Acquired by Morningside Pharmaceuticals (Oct 2022)
- Annual Revenue$101.09 M (USD)30as on Dec 31, 2022
- Net Profit$24.3 M (USD)-2as on Dec 31, 2023
- InvestorsMorningside Pharmaceuticals
& 1 more
- Investments & AcquisitionsCenote Pharma
& 2 more
- Acquired by
Investors in Aspire Pharma
Aspire Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Morningside Pharmaceuticals and H.I.G. Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity capital is invested in small and mid-sized businesses. | higcapital.com | Miami, United States | ||
Healthcare products are distributed diversely across sectors by Morningside Pharmaceuticals. | 1991 | morningsidepharm.com | Loughborough, United Kingdom |
Investor details for Aspire Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aspire Pharma
Aspire Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cenote Pharma, Morningside Healthcare and Morningside Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medicines for rare metabolic disorders are developed by Cenote Pharma. | cenotepharma.co.uk | Newbury, United Kingdom | 2015 | Mar 2024 | •••• | |
Provider of medicinal products supply chain and logistic services for pharmaceutical industry | morningsidehealthcare.com | Leicester, United Kingdom | 2001 | Oct 2022 | •••• | |
Healthcare products are distributed diversely across sectors by Morningside Pharmaceuticals. | morningsidepharm.com | Loughborough, United Kingdom | 1991 | Oct 2022 | •••• |
Complete acquisition details for Aspire Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aspire Pharma
6 dated milestones of Aspire Pharma across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Aspire Pharma is founded.
- Exit Acquired by H.I.G. Capital.
- Acquisition Acquires Morningside Pharmaceuticals.
- Acquisition Acquires Morningside Healthcare.
- Exit Acquired by Morningside Pharmaceuticals.
- Acquisition Acquires Cenote Pharma.
Web traffic of Aspire Pharma
The website of Aspire Pharma (aspirepharma.co.uk) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 41.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aspire Pharma
Aspire Pharma was founded in 2009.
Aspire Pharma is headquartered in Petersfield, United Kingdom. It is registered at Petersfield, Hampshire, United Kingdom.
Annual revenue of Aspire Pharma is $101.09M as on Dec 31, 2022.
Aspire Pharma was founded in 2009 as a British pharmaceutical company based in Petersfield, United Kingdom. Operations focus on in-licensing and commercializing therapeutic drugs and medical devices across categories such as anti-microbials, anti-fungals, proton pump inhibitors, anti-allergy treatments, cardiac medications, central nervous system and psychiatry products, and analgesics. The company serves the traditional pharma sector with a portfolio targeted at various therapeutic needs.
Aspire Pharma has made 3 acquisitions, including Cenote Pharma, Morningside Healthcare, and Morningside Pharmaceuticals.
Aspire Pharma has 2 investors. Key investors include Morningside Pharmaceuticals, and H.I.G. Capital.
Yes. Aspire Pharma was acquired by Morningside Pharmaceuticals in October 2022.